The global clinical trial supplies market was valued at USD 2.58 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030. Key drivers of this growth include the globalization of clinical trials and the increasing number of biologic and biosimilar drugs in development. Biologic and biosimilar drugs are particularly complex and often...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian